Format

Send to

Choose Destination
Angew Chem Int Ed Engl. 2019 Feb 11;58(7):2050-2054. doi: 10.1002/anie.201812878. Epub 2019 Jan 16.

Precise In Vivo Inflammation Imaging Using In Situ Responsive Cross-linking of Glutathione-Modified Ultra-Small NIR-II Lanthanide Nanoparticles.

Author information

1
Department of Chemistry, Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, State Key Laboratory of Molecular Engineering of Polymers and iChem, Fudan University, Shanghai, 200433, P. R. China.

Abstract

To improve the bioimaging signal-to-noise ratio (SNR), long-term imaging capability, and decrease the potential biotoxicity, an in vivo cross-linking strategy was developed by using sub-10 nm, glutathione-modified, lanthanide nanoprobes. After administration, the nanoprobes cross-link in response to reactive oxygen species (ROS) at the inflamed area and enable the quick imaging of ROS in the second near-infrared (NIR-II) window. These nanoprobes could be rapidly excreted due to their ultra-small size. This strategy may also be applied to other ultra-small contrast agents for the precise bioimaging by in situ lesion cross-linking.

KEYWORDS:

NIR-II bioimaging; inflammation; in vivo cross-linking; lanthanide; ultra-small nanoparticles

PMID:
30589175
DOI:
10.1002/anie.201812878

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center